UnitedHealth Group Incorporated $UNH Shares Purchased by Osprey Private Wealth LLC

Osprey Private Wealth LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 96.3% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,646 shares of the healthcare conglomerate’s stock after purchasing an additional 5,714 shares during the quarter. Osprey Private Wealth LLC’s holdings in UnitedHealth Group were worth $4,841,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Sarver Vrooman Wealth Advisors bought a new position in UnitedHealth Group in the 4th quarter valued at about $25,000. Anfield Capital Management LLC increased its position in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $27,000. Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $27,000. Finally, Lifetime Wealth Management P.C. acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $29,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.6%

Shares of UnitedHealth Group stock opened at $401.52 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The stock has a 50-day moving average price of $415.74 and a 200 day moving average price of $352.85. The company has a market cap of $360.40 billion, a P/E ratio of 25.84, a P/E/G ratio of 1.39 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 19.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is 59.72%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on UNH. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Royal Bank Of Canada boosted their target price on UnitedHealth Group from $463.00 to $478.00 and gave the stock an “outperform” rating in a research report on Friday, July 17th. Barclays increased their price target on UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a report on Wednesday, May 27th. Finally, Piper Sandler set a $477.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $455.92.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 500 shares of UnitedHealth Group stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total transaction of $205,000.00. Following the completion of the sale, the chief executive officer directly owned 16,497 shares in the company, valued at $6,763,770. The trade was a 2.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.